Teniposide-treated tumor cells can activate the anti-tumor T cell response and DC maturation both in vitro and in vivo, and potentiate the anti-tumor efficacy of anti-PD1 in mouse multiple-type tumor models [19]. Here, PDCD1 is linked to neoplasm.